Cargando…
Current Status of CTCs as Liquid Biopsy in Lung Cancer and Future Directions
Circulating tumor cells (CTCs) have garnered a lot of attention in the past few decades. Isolation of these rare cells from the billions of blood cells has been a challenge until recent times. With the advent of new sensitive technologies that permit live cell isolation and downstream genomic analys...
Autores principales: | Zhang, Zhuo, Ramnath, Nithya, Nagrath, Sunitha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4588111/ https://www.ncbi.nlm.nih.gov/pubmed/26484313 http://dx.doi.org/10.3389/fonc.2015.00209 |
Ejemplares similares
-
Immunotherapy for ALK-Rearranged Non-Small Cell Lung Cancer: Challenges Inform Promising Approaches
por: Sankar, Kamya, et al.
Publicado: (2021) -
Expansion of CTCs from early stage lung cancer patients using a microfluidic co-culture model
por: Zhang, Zhuo, et al.
Publicado: (2014) -
Optimizing the Detection of Circulating Markers to Aid in Early Lung Cancer Detection
por: Murlidhar, Vasudha, et al.
Publicado: (2016) -
ctDNA and CTCs in Liquid Biopsy – Current Status and Where We Need to Progress
por: Neumann, Martin H.D., et al.
Publicado: (2018) -
Liquid biopsy in hematological malignancies: current and future applications
por: Talotta, Donatella, et al.
Publicado: (2023)